CompletedNot Applicable

Prehabilitation for Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients

United States90 participantsStarted 2021-10-05

Plain-language summary

This clinical trial evaluates whether a prehabilitation program started at the time of neoadjuvant chemotherapy will affect surgical recovery in patients with stage IIIC-IV ovarian, fallopian tube, or primary peritoneal cancer. A prehabilitation program may improve the quality of life after surgery for patients with ovarian, fallopian tube, or primary peritoneal cancer.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age \>= 18 years old * Diagnosed with epithelial ovarian, fallopian tube, or primary peritoneal cancer based on imaging and physician diagnosis * Suspected Stage IIIC or IV disease based on clinician staging and imaging * Curative intent treatment with platinum-based chemotherapy * Planned surgical intervention at some point during treatment course * Ability to read English * No diagnosed severe cognitive impairment * Ability to provide consent * Ability to utilize technology to watch online modules for the Resilient Living Program Exclusion Criteria: * Hemiplegia or paraplegia * Current pregnancy

What they're measuring

Adherence to each prehabilitation component based on patient reported adherence (Cohorts 2 & 3)

Timeframe: Weekly up to 4 months

Trial details

NCT IDNCT05047926

SponsorMayo Clinic

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-07-08

View on ClinicalTrials.gov More Advanced Ovarian Carcinoma trials